Physician profile
Raphael Lilker
NPI 1396011581
$2,294.27
in general payments reported to CMS, 2019-2025
14 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $600 · 2021: $73.86 · 2022: $667 · 2023: $338 · 2024: $161 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $863.31 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $713.22 | 2020-2025 | Jublia, Bryhali |
| Medimetriks Pharmaceuticals, INC. | $370.95 | 2019-2020 | |
| Sandoz INC. | $84.28 | 2019-2020 | |
| Stryker Corporation | $42.98 | 2022 | |
| Fidia Pharma USA INC. | $39.33 | 2021-2023 | Hymovis, Triluron |
| Treace Medical Concepts, INC. | $36.95 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $31.02 | 2023 | Seglentis |
| Dynasplint Systems INC. | $25.41 | 2023 | Dynasplint |
| Integra Lifesciences Corporation | $23.36 | 2019 | |
| Smith+Nephew, INC. | $20.95 | 2022 | |
| Journey Medical Corporation | $19.47 | 2021 | |
| Sebela Pharmaceuticals INC. | $18.80 | 2022 | |
| Orthofix Medical, INC. | $4.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Lilker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.